Table 2 Race distribution of TCGA and NAACCR cases

From: Characteristics of The Cancer Genome Atlas cases relative to U.S. general population cancer cases

Cancer types

Total

White

Black

Other

TCGA N

NAACCR N

TCGA N (%)

NAACCR N (%)

TCGA N (%)

NAACCR N (%)

TCGA N (%)

NAACCR N (%)

All cancers

5899

4,834,006

4845 (82.1)

4,118,891 (85.2)

500 (8.5)

548,447 (11.3)

554 (9.4)

166,668 (3.4)

BLCA

394

335,620

327 (83.0)

310,352 (92.5)

23 (5.8)

18,912 (5.6)

44 (11.2)

6356 (1.9)

BRCA

1002

1,085,443

758 (75.7)

913,884 (84.2)

183 (18.3)

128,208 (11.8)

61 (6.1)

43,351 (4.0)

CESC

271

59,092

221 (81.6)

46,030 (77.9)

30 (11.1)

9902 (16.8)

20 (7.4)

3160 (5.4)

COAD

285

477,271

215 (75.4)

397,760 (83.3)

59 (50.6)

62,360 (13.1)

11 (3.9)

17,151 (3.6)

ESCA

165

78,445

114 (69.1)

68,590 (87.4)

5 (3.0)

8034 (10.2)

46 (27.9)

1821 (2.3)

HNSC

513

416,929

454 (88.5)

364,624 (87.5)

48 (9.4)

40,315 (9.7)

11 (2.1)

11,990 (2.9)

LAML

198

65,266

181 (91.4)

56,612 (86.7)

15 (7.6)

5983 (9.2)

2 (1.0)

2671 (4.1)

LIHC

367

131,074

189 (51.5)

100,398 (76.6)

17 (4.6)

19,865 (15.2)

161 (43.9)

10,811 (8.3)

MESO

87

15,705

85 (97.7)

14,745 (93.9)

1 (1.2)

740 (4.7)

1 (1.2)

220 (1.4)

OV

556

102,308

502 (90.3)

88,406 (86.4)

34 (6.1)

9521 (9.3)

20 (3.6)

4381 (4.3)

PAAD

180

205,375

162 (90.0)

172,558 (84.0)

7 (3.9)

25,856 (12.6)

11 (6.1)

6961 (3.4)

PRAD

156

944,300

147 (94.2)

768,438 (81.4)

7 (4.5)

153,082 (16.2)

2 (1.3)

22,780 (2.4)

READ

89

188,774

82 (92.1)

157,903 (83.7)

6 (6.7)

21,534 (11.4)

1 (1.1)

9337 (5.0)

SARC

252

51,566

228 (90.5)

43,208 (83.8)

18 (7.1)

6336 (12.3)

6 (2.4)

2022 (3.9)

SKCM

460

314,232

447 (97.2)

311,095 (99.0)

1 (0.2)

1747 (0.6)

12 (2.6)

1390 (0.4)

STAD

381

108,778

279 (73.2)

83,030 (76.3)

13 (3.4)

17,535 (16.1)

89 (23.4)

8213 (7.6)

TGCT

129

38,765

119 (92.3)

36,311 (93.7)

6 (4.7)

1380 (3.6)

4 (3.1)

1074 (2.8)

THCA

414

215,063

335 (80.9)

184,947 (86.0)

27 (6.5)

17,137 (8.0)

52 (12.6)

12,979 (6.0)

  1. BLCA bladder urothelial carcinoma, BRCA breast invasive carcinoma, CESC cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD colon adenocarcinoma, ESCA oesophageal carcinoma, HNSC head and neck squamous cell carcinoma, LAML acute myeloid leukaemia, LIHC liver hepatocellular carcinoma, MESO mesothelioma, OV ovarian serous cystadenocarcinoma, PAAD pancreatic adenocarcinoma, PRAD prostate adenocarcinoma, READ rectum adenocarcinoma, SARC sarcoma, SKCM skin cutaneous melanoma, STAD stomach adenocarcinoma, TGCT testicular germ cell tumours, THCA thyroid carcinoma.
  2. Note: 18 cancer types were included